Hosted By

Powered By

Christine Ann Miller, President and Chief Executive Officer of Melinta Therapeutics

Since August 2020, Christine Ann Miller has served as the President and Chief Executive Officer, as well as a board member, at Melinta Therapeutics, a commercial-stage company and leader in acute care that provides innovative therapies for acute and life-threatening illnesses. Ms. Miller is a global pharmaceutical veteran with more than 20 years of experience in life sciences.

Prior to joining Melinta, Ms. Miller led the global and U.S. product portfolio for Sandoz, a $10 billion division of Novartis, where she was accountable for transitioning the portfolio toward rapid-growth and higher-margin segments, such as complex generics and value- added medicines, while continuing to build the branded generics business.

Among her various achievements, Ms. Miller directed more than 50 product launches that generated over $300 million of new annual revenue, closed numerous business development acquisitions, and built a robust five-year development and acquisition product pipeline. Before Sandoz, Ms. Miller spent over a decade at Actavis (now Allergan) and its predecessor Watson Pharmaceuticals where she led the preparation of numerous product launches and held leadership roles in both R&D operations and supply chain management.

Ms. Miller’s leadership focus combines her passion for building and leading high performing teams with goal-driven operational rigor. She articulates a clear mission, vision and strategy that engages people to cohesively work towards creative problem solving and innovative solutions.

In addition to her role at Melinta, Ms. Miller serves on the Board of Directors of IVERIC bio, Inc., a biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases. Her Board committee assignments include the Research and Development Committee and the Nominating and Corporate Governance Committee. She is an Advisory Board Member for the Healthcare Businesswomen’s Association and is a frequent panelist and speaker at industry events. More recently, Ms. Miller joined the Stevens Institute of Technology President’s Leadership Council where she serves alongside accomplished thought leaders from academe, industry, and the non-profit sectors. For this appointment, she provides expertise and guidance to the President and the Board as Stevens advances its plan to become an internationally recognized center of excellence in education, research and technological innovation.

Ms. Miller started her career at Merck as a chemical engineer and procurement analyst and earned an MBA and a Master’s in Technology Management at Stevens Institute of Technology and a B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.